Professional Documents
Culture Documents
Roches Acquisition of Genentech
Roches Acquisition of Genentech
Roches Acquisition of Genentech
270 50%
125 0%
112 100%
107 100%
124 75%
113 37%
851
EV 74906.751
DEBT VALUE( EX-5) -CP+LTD 2829
PLUS: CASH AND STMS 7000
$89
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
10868
2409
258
13535 14482.45 15496.222 16580.957 17741.624 18983.538 20312.385 21734.252 23255.65 24883.545
1285.825
6483.265 6937.0936 7422.6901 7942.2784 8498.2379 9093.1145 9729.6326 10410.707 11139.456 11919.218
2269.1428 2427.9827 2597.9415 2779.7974 2974.3833 3182.5901 3405.3714 3643.7474 3898.8097 4171.7264
4214.1223 4509.1108 4824.7486 5162.481 5523.8546 5910.5245 6324.2612 6766.9594 7240.6466 7747.4919
446.655 477.92085 511.37531 547.17158 585.47359 626.45674 670.30872 717.23033 767.43645 821.157
175.955 188.27185 201.45088 215.55244 230.64111 246.78599 264.06101 282.54528 302.32345 323.48609
4484.8223 4798.7598 5134.673 5494.1001 5878.6871 6290.1952 6730.5089 7201.6445 7705.7596 8245.1628
527.865 564.81555 604.35264 646.65732 691.92334 740.35797 792.18303 847.63584 906.97035 970.45827
3956.9573 4233.9443 4530.3204 4847.4428 5186.7638 5549.8372 5938.3258 6354.0087 6798.7893 7274.7045
0.9174312 0.84168 0.7721835 0.7084252 0.6499314 0.5962673 0.5470342 0.5018663 0.4604278 0.4224108
3630.236 3405.1615 3342.6815 3281.3479 3221.1397 3162.0362 3104.0172 3047.0627 2991.1533 2936.2698
DF @ 9%
GR OF 2%
M GROWTH RATE
2% 3% 4%
PRICE PER SHARE
GROWTH 0%,1%,2%,3%,$%,5%
CHANGE IN WC
101289.18
0.4224108 FCFF=NOPAT+D-CHANGES IN NWC-CAPEX
42785.645
EV=PV OF FCFF-DEBT-PSC-MI+CASH AND CE
VALUE BASED ON NFM (GS)
(in millions of US dollar)
2006 2007 2008 2009 2010
revenues
product sales 7640 9443 10531 10868
royalties 1354 1984 2539 2409
contract and other 290 297 348 258
total revenue 9284 11724 13418 13535 14482.45
EV 74906.75
DEBT VALUE( EX-5) -CP+LTD 2829
PLUS: CASH AND STMS 7000 DF @ 9%
GR OF 2%
EQUITY VALUE 79077.75
112-115
2011 2012 2013 2014 2015 2016 2017 2018
0.04